| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.7162 | 51 |
| GSM780708 | Untreated after 4 days (C2_1) | 50.0548 | 49 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.9191 | 48 |
| GSM780719 | Untreated after 4 days (C1_2) | 53.0766 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.5851 | 35 |
| GSM780721 | Untreated after 4 days (C3_2) | 54.937 | 59 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 45.3718 | 29 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.6445 | 30 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 54.606 | 59 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.6485 | 47 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.6133 | 44 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.4612 | 24 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 51.5994 | 53 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 51.2711 | 52 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 54.3346 | 58 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.2826 | 52 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 52.7885 | 56 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.3968 | 34 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 53.9513 | 58 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 48.8631 | 45 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.0657 | 45 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.7449 | 48 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.3503 | 43 |